Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Tolerability of Antistax in Chronic Venous Insufficiency
NCT00855179Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic venous insufficiency (CVI) comparing Antistax with Placebo (2 arms). Primary endpoint: Change from baseline in limb volume determination at 84 days. Started Mar 2009; status: completed.
02
Drugs
Red vine leaf extract
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT00855179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855179.